Use of Renin–Angiotensin–Aldosterone System Inhibitors in Older Patients with Heart Failure and Reduced Ejection Fraction
Patients enrolled in randomised clinical trials may not be representative of the real-world population of people with heart failure (HF). Older patients are frequently excluded and this limits the strength of evidence which supports the use of specific HF treatments in this patient group. Lack of ev...
Enregistré dans:
Auteurs principaux: | Davide Stolfo, Gianluigi Savarese |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Radcliffe Medical Media
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f4ce5f907c0d4c6c8732a6a7a88c5b12 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction
par: Giuseppe MC Rosano, et autres
Publié: (2019) -
The impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction
par: Osama A. Amin, et autres
Publié: (2021) -
The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
par: Eliecer Coto, et autres
Publié: (2021) -
Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)
par: Berkay Ekici, et autres
Publié: (2021) -
Role of nutritional supplementation in heart failure with reduced ejection fraction
par: Yash Paul Sharma, et autres
Publié: (2021)